Xencor Inc
For the period ended Jun 30, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
(c) Rule 10b5-1 Plans
During the fiscal quarter ended June 30, 2026, no director or officer (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended)adopted orterminated a trading arrangement, including a Rule 10b5-1 trading arrangement (as defined in Item 408(a)(1)(i) of Regulation S-K) or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K), except as set forth in the following table:
| Name | Title | Adoption Date | Termination Date | Duration(1) | Aggregate Number of Shares of Common Stock to be Sold Pursuant to Trading Arrangement |
|---|---|---|---|---|---|
| John R. Desjarlais | Chief Scientific Officer | 6/1/2026 | 6/23/2026 | 2/12/2027 | 41,883 |
(1) The trading arrangement permitted transactions through and including the earlier to occur of (a) the date that all shares subject to the trading arrangement have been sold and (b) the date listed in the table. However, this trading arrangement was subsequently terminated on June 23, 2026 prior to the sale of any shares.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.